C
hikungunya virus (CHIKV) is a mosquito-transmitted alphavirus that causes epidemics of incapacitating musculoskeletal inflammatory disease in humans. Since 2004, CHIKV has infected millions of people and expanded into Europe, the Middle East, and the Pacific region (1) . In 2013, local transmission of CHIKV occurred in the Western Hemisphere on islands in the Caribbean (2) . Since then, CHIKV has caused more than 1.8 million cases in the Americas in more than 40 countries (3) . Acute CHIKV disease is characterized by high fever with severe joint pain, joint swelling, and muscle pain (4) . Severe outcomes, including death, occur in neonates, the elderly, and those with underlying medical comorbidities (5, 6) . Rheumatologic disease signs and symptoms can last for months to years in up to 60% of infected individuals (7) (8) (9) (10) (11) (12) (13) (14) , which causes a substantial economic burden and loss of quality of life (15, 16) . Vaccines and antiviral agents are not approved for CHIKV infection, and treatment is currently limited to managing symptoms with analgesics and anti-inflammatory drugs (17) .
Although the mechanisms by which CHIKV infection leads to chronic disease remain poorly characterized, CHIKV antigen and RNA have been detected in synovial and muscle tissue biopsy specimens collected from patients during the chronic phase of disease (18, 19) . Consistent with these data, long-term persistence of CHIKV infection and chronic joint disease occur in experimentally infected nonhuman primates (NHPs) and mice (20) (21) (22) (23) (24) , suggesting that residual virus or viral products in tissues may promote chronic inflammation.
Previous studies demonstrated that adaptive immune responses control CHIKV infectivity during the persistent phase but are unable to clear CHIKV RNA from jointassociated tissue (24, 25) . Moreover, CHIKV evades neutralizing antibody responses as a necessary step to establish persistence (23) . CHIKV likely uses multiple evasion mechanisms to establish and maintain persistence, as persistent CHIKV infection develops in the setting of sustained innate and adaptive antiviral immune responses. For example, in addition to being essential for the control of CHIKV infection during the acute phase (26) , the type I interferon (IFN) response is maintained for many weeks in humans with chronic CHIKV disease and in mice persistently infected with CHIKV (18, 25, 27) . Furthermore, CHIKV-specific antibody and T cell responses endure for weeks to months postinfection (p.i.) (21, (28) (29) (30) . Thus, we hypothesized that the persistence of CHIKV infection requires the acquisition of adaptive mutations to escape host selective pressures.
To explore this hypothesis, we isolated virus from ankle tissue and serum of B celland T cell-deficient Rag1 Ϫ/Ϫ mice on day 28 following infection with the Asian CHIKV strain AF15561. Unexpectedly, plaque-purified CHIKV from the serum of chronically infected Rag1 Ϫ/Ϫ mice displayed enhanced acute pathogenicity when inoculated into naive wild-type (WT) mice. Sequence analysis identified polymorphisms in the viral E2 glycoprotein and the 3= untranslated region (3=-UTR) that, when introduced into the parental CHIKV strain AF15561, conferred enhanced virulence in WT mice. Reverse genetic analysis showed that while mutations in both E2 and the 3=-UTR contributed to enhanced pathogenicity, an enhanced capacity to disseminate more rapidly from the site of inoculation was linked to a single K200R mutation in E2. Studies in immunocompromised mice revealed that the E2 K200R mutation enhanced the ability of CHIKV to disseminate in a manner that was independent of IFN regulatory factor 3 (IRF3)-, IRF7-, and IFNAR1-dependent antiviral responses. Overall, our studies provide new insight into the viral determinants of CHIKV dissemination and virulence.
RESULTS
Isolation of a CHIKV strain with enhanced pathogenicity in WT mice. We hypothesized that during persistent infection, CHIKV acquires adaptive mutations to facilitate persistence in specific tissues. To investigate this idea, we took advantage of the observations that Rag1 Ϫ/Ϫ and Rag2 Ϫ/Ϫ mice, in contrast to WT mice, support persistent viremia for weeks to months after CHIKV infection but do not succumb to disease (24, 25, 31) . To assess whether infectious CHIKV circulating in the serum of Rag1 Ϫ/Ϫ mice had adapted to host pressures during persistence, WT mice were inoculated in the left rear footpad with 20 l of serum collected from five individual viremic Rag1 Ϫ/Ϫ mice at 28 days postinfection (dpi). In parallel, WT mice were inoculated in the left rear footpad with 10 3 PFU of AF15561 stock virus or 20 l of a clarified right-ankle tissue homogenate collected from five individual CHIKV-infected Rag1 Ϫ/Ϫ mice at 28 dpi. The inoculated sera or ankle tissue homogenates each contained between 10 and 20 PFU of infectious virus, as measured by a direct plaque assay (23) . Mice were monitored daily for virus-induced changes in weight as a measure of disease. Four of five mice inoculated with serum from persistently infected Rag1 Ϫ/Ϫ mice failed to gain weight through day 10 p.i. compared with those inoculated with AF15561 (P Ͻ 0.001) (Fig. 1A) . In contrast, and consistent with data from previous studies, WT mice infected with CHIKV AF15561 gained weight throughout the course of infection (Fig. 1A ). Mice inoculated with ankle tissue homogenates from CHIKV-infected Rag1 Ϫ/Ϫ mice showed weight gain similar to that of AF15561-infected mice (P Ͼ 0.05). Furthermore, mice inoculated with serum from persistently infected Rag1 Ϫ/Ϫ mice exhibited more severe musculoskeletal disease signs, including hind limb grip loss, altered gait, and difficulty righting (data not shown). These data suggested that CHIKV AF15561 in the circulation, but not ankle tissue, of Rag1 Ϫ/Ϫ mice at 4 weeks postinfection had acquired adaptive mutations that enhanced acute pathogenesis in naive WT mice.
One alternative explanation for the enhanced disease observed in WT mice inoculated with serum from persistently infected Rag1 Ϫ/Ϫ mice was the coinoculation of factors present in the serum of chronically infected Rag1 Ϫ/Ϫ mice that enhanced virus-induced disease. To eliminate this possibility, we plaque purified CHIKV from one of the Rag1 Ϫ/Ϫ serum samples that caused severe disease in WT mice (Fig. 1A, arrow) . Stocks of individual plaque-purified isolates AF6811P1 to AF6811P6 were generated by a single amplification on Vero cells. WT mice were inoculated with 10 PFU of AF15561 or plaque-purified isolates AF6811P1 to -P3 and monitored for virus-induced effects on weight gain. In contrast to mice inoculated with AF15561, mice inoculated with the plaque-purified viruses exhibited reduced weight gain (Fig. 1B) and more severe musculoskeletal disease signs (Fig. 1C) . As the plaque-purified viral isolates retained the enhanced virulence of Rag1 Ϫ/Ϫ mouse serum-derived AF15561, other serum factors were not responsible for the more severe disease signs.
Sequencing analysis identifies mutations in E2, E1, and the 3=-UTR. We sequenced the complete viral genome of plaque-purified isolate AF6811P2 both at the consensus level and by Illumina-based deep sequencing. Alignment of sequence reads obtained by both methods to the reference CHIKV AF15561 genome identified three mutations in the genome of AF6811P2: a lysine (K)-to-arginine (R) substitution at E2 position 200 (E2 K200R), a synonymous A-to-G mutation in the E1 gene (nucleotide [nt] 10506), and a 44-nt deletion in the 3=-UTR ( Table 1 ). The deep-sequencing results indicated that these mutations were present in 98.5% or more of the sequence reads, suggesting that the AF6811P2 plaque-purified virus was clonal. We also sequenced E2 position 200 and the 3=-UTR in the other five plaque-purified isolates and found that each isolate contained an E2 K200R mutation, with the exception of AF6811P3, which had a mutation to glutamine at this position (E2 K200Q) ( Table 2) . A 44-nt deletion identical to the deletion present in the 3=-UTR of AF6811P2 was present in three of the other plaque isolates but notably was absent in two others ( Table 2 ), suggesting that this deletion was selected after the mutation at E2 position 200. E2 residue 200 is located in domain B and, based on the crystal structure of the pE2-E1 heterodimer (32) , is predicted to make contacts with E1 residues 63 and 95 located in the fusion loop of E1 (Fig. 1D) . Analysis of sequence variation among the 335 available CHIKV genomes in the NIAID ViPR database (33) revealed that 333/335 genomes (Ͼ99%) code for a K residue at position 200 in E2. The remaining two genomes, isolated from a patient in Thailand in 1995 (SV0444-95) and from a mosquito from the Ivory Coast in 1993 (ArA 30548), encode an R residue at this site, suggesting that the K200R mutation occurs in nature. The 44-nt deletion occurs in a duplicated region of the 3=-UTR that is unique to Asian genotype viruses (Fig. 1E) . The 44-nt sequence is also highly conserved, with CHIKV strains across all genotypes encoding one or two copies of this sequence in the 3=-UTR (see Table S1 in the supplemental material).
To confirm that these mutations were responsible for the enhanced virulence of the adapted AF6811P2 strain, the E2 K200R mutation and the 3=-UTR deletion were introduced into the plasmid carrying the parental AF15561 cDNA genome to generate AF15561 E2 K200R;ΔUTR . WT mice were inoculated in the footpad with 10 3 PFU of WT strain AF15561, AF6811P2, or AF15561 E2 K200R;ΔUTR , and mice were monitored for weight gain and musculoskeletal disease ( Fig. 1F and G). Similar to AF6811P2-infected mice, AF15561 E2 K200R;ΔUTR -infected mice exhibited diminished weight gain compared with mice inoculated with AF15561 ( Fig. 1F ), and remarkably, 1 of 4 mice in both groups succumbed to infection by day 10 p.i. Additionally, both AF6811P2-and AF15561 E2 K200R;ΔUTR -infected mice exhibited more severe signs of musculoskeletal disease than did mice inoculated with AF15561 ( Fig. 1G ). At 7 dpi, WT mice inoculated with AF15561 E2 K200R;ΔUTR also displayed more severe inflammation and injury in tissues distal to the site of inoculation, including the ipsilateral and contralateral gastrocnemius muscles (leg) and thighs ( Fig. 2A and B) . Notably, mice infected with AF6811P2 and AF15561 E2 K200R;ΔUTR did not develop more severe swelling of the inoculated foot than did AF15561-infected mice (data not shown). These data indicate that an E2 K200R mutation and a deletion of 44 nt in the 3=-UTR enhance systemic disease and injury in musculoskeletal tissues distal to the site of inoculation.
AF15561 E2 K200R;⌬UTR displays enhanced dissemination and infection at early times. Based on the failure of mice infected with AF15561 E2 K200R;ΔUTR to gain weight early after infection, we hypothesized that these mutations enhanced viral replication in tissues at early time points p.i. To evaluate viral dissemination and tissue burdens, WT mice were inoculated in the left rear footpad with either AF15561 or AF15561 E2 K200R;ΔUTR , and the amount of infectious virus proximal or distal to the site of inoculation was quantified at 1 and 3 dpi. Both AF15561 and AF15561 E2 K200R;ΔUTR achieved similar titers at 1 and 3 dpi in the left ankle tissue, which is proximal to the inoculation site ( Fig. 3A and B) . In contrast to the left ankle, AF15561 E2 K200R;ΔUTR rapidly disseminated to distant tissues and achieved higher titers than those in AF15561-infected mice by 1 dpi ( . Similarly, AF15561 E2 K200R;ΔUTR -infected mice had a higher level of viremia than did AF15561-infected mice at both 1 dpi (1,000-fold; P Ͻ 0.001) and 3 dpi (1,050-fold; P Ͻ 0.01) ( Fig. 3A and B) . Together, these data suggest that the E2 K200R mutation and the 44-nt deletion in the 3=-UTR enhance the ability of CHIKV to disseminate from the site of inoculation.
FIG 1 Legend (Continued)
Central, and South African (ECSA); and Asian genotype CHIKV strains, including the AF6811P2 Asian strain plaque isolated from the serum of chronically infected Rag1 Ϫ/Ϫ mice. UTR sequence features were annotated according to methods described previously by Chen et al. (65) . Direct repeats are labeled and illustrated by different-colored blocks. Sequence gaps in the alignment are indicated by white blocks. (F and G) WT C57BL/6J mice were inoculated with 10 3 PFU of AF15561 (n ϭ 4), AF6811P2 (n ϭ 4), or AF15561 E2 K200R;ΔUTR (n ϭ 4) in the left rear footpad. The percent starting body weight (F) and disease score (G) were determined daily. P values were determined by two-way ANOVA with Bonferroni's multiple-comparison test. ***, P Ͻ 0.001; ****, P Ͻ 0.0001. To investigate if the E2 K200R and the 3=-UTR mutations altered viral replication in cells in vitro, we performed multistep viral growth analysis in murine fibroblasts and differentiated murine C2C12 muscle cells, key cell type targets in vertebrate hosts (26, 34) , and in mosquito-derived C6/36 cells. Virus yields from murine fibroblasts and murine C2C12 muscle cells inoculated with AF15561 or AF15561 E2 K200R;ΔUTR at a low multiplicity of infection (MOI) (0.1 and 0.01 focus-forming units [FFU]/cell, respectively) were similar at 12, 24, and 48 h postinoculation (hpi) (Fig. 4A and B) . The yields of infectious virus were reduced in C6/36 mosquito cells infected with AF15561 E2 K200R;ΔUTR (Fig. 4C) ; however, the magnitude of these differences was small, only 2-to 3-fold. These data, together with the data demonstrating no differences in viral loads at the site of inoculation of mice ( Fig. 3A and B) , suggest that the E2 K200R and 3=-UTR mutations predominantly impact viral dissemination in vivo.
The adaptive mutations enhance early viral dissemination independent of IRF3, IRF7, and IFNAR1. The type I IFN pathway has an important role in restricting CHIKV replication in mice (26, (35) (36) (37) (38) . Mice deficient in the transcription factors that induce type I IFN (IRF3 and IRF7) or in a required subunit of the type I IFN receptor (IFNAR1) are more susceptible to CHIKV infection, with elevated viral burdens in many tissues, analogous to our results with WT mice infected with the AF15561 E2 K200R;ΔUTR mutant virus. We hypothesized that the enhanced viral burdens observed at early times after infection of WT mice with AF15561 E2 K200R;ΔUTR might be due to greater antagonism of the type I IFN response. To explore this possibility, we compared AF15561 and AF15561 E2 K200R;ΔUTR infections in Irf3 Ϫ/Ϫ Irf7 Ϫ/Ϫ double-knockout (DKO) mice, which are compromised for the production of type I IFN following CHIKV infection (36, 37) . Regardless of the mouse strain, AF15561 and AF15561 E2 K200R;ΔUTR achieved similar titers in the left ankle tissue after ipsilateral footpad inoculation (Fig. 5A) . In both WT and Irf3 Ϫ/Ϫ Irf7 Ϫ/Ϫ DKO mice, AF15561 E2 K200R;ΔUTR rapidly disseminated and achieved higher viral loads than those in AF15561-infected mice in the right ankle (Fig. 5A) . Quantification of IFN-␣ levels in the sera of naive and CHIKV-infected mice at 1 dpi confirmed that Irf3 Ϫ/Ϫ Irf7 Ϫ/Ϫ DKO mice failed to produce type I IFN in response to CHIKV infection (Fig. 5B ). In addition, we found that IFN-␣ levels in the sera of WT mice infected with AF15561 E2 K200R;ΔUTR at 1 dpi were higher than those in the sera of AF15561-infected WT mice (Fig. 5B) , demonstrating that AF15561 E2 K200R;ΔUTR infection induces a robust type I IFN response. Consistent with the findings for Irf3 Ϫ/Ϫ Irf7 Ϫ/Ϫ DKO mice, AF15561 E2 K200R;ΔUTR rapidly disseminated and achieved higher viral loads than did parental strain AF15561 in Ifnar1 Ϫ/Ϫ mice (Fig.  5C ). These data suggest that the E2 K200R mutation and the 44-nt deletion in the 3=-UTR enhance the capacity of the virus to rapidly disseminate from the inoculation site by a mechanism that is independent of the evasion or suppression of the type I IFN response, although a role for IRF5-dependent antiviral responses (39) cannot be ruled out. Both the E2 K200R mutation and the 3=-UTR deletion contribute to enhanced disease severity. To evaluate the contribution of each mutation individually to the disease phenotype observed in WT mice infected with AF15561 E2 K200R;ΔUTR , we constructed AF15561 strains encoding either the E2 K200R mutation (AF15561 E2 K200R ) or the 3=-UTR deletion (AF15561 ΔUTR ). WT mice were inoculated with AF15561, AF15561E2 K200R;ΔUTR, AF15561 E2 K200R , or AF15561 ΔUTR and monitored daily for morbidity and musculoskeletal disease ( Fig. 6A and B ). Mice infected with AF15561 E2 K200R failed to gain weight (P Ͻ 0.0001) and developed more severe musculoskeletal disease (P Ͻ 0.0001) than did AF15561-infected mice, suggesting that the E2 K200R mutation contributes to enhanced pathogenesis in mice. In contrast, mice infected
FIG 3
Mutations in E2 and the 3=-UTR enhance viral dissemination and tissue burdens in WT mice. WT C57BL/6 mice were inoculated with 10 3 PFU of AF15561 or AF15561 E2 K200R;ΔUTR in the left rear footpad. At 1 dpi (n ϭ 9 mice/group) (A) or 3 dpi (n ϭ 5 mice/group) (B), mice were euthanized, and the amount of infectious virus in the indicated tissues was quantified by a focus-forming assay. Dashed lines indicate the limit of detection. Data are derived from results from two independent experiments. P values were determined by Mann-Whitney tests. *, P Ͻ 0.05; **, P Ͻ 0.01; ***, P Ͻ 0.001; ****, P Ͻ 0.0001. with AF15561 ΔUTR gained weight similarly to AF15561-infected mice (P Ͼ 0.05) and exhibited similar mild musculoskeletal disease signs, suggesting that this deletion alone is not sufficient to enhance virulence. However, at later times postinfection (days 9 to 14 p.i.), mice infected with AF15561 E2 K200R more readily gained weight (Fig. 6A ) and displayed less musculoskeletal disease than did AF15561 E2 K200R;ΔUTR -infected mice (days 6 to 14 p.i.) (Fig. 6B) , suggesting that when combined with the E2 K200R mutation, the 3=-UTR deletion enhances the pathogenicity of CHIKV in mice.
The E2 K200R mutation enhances viral dissemination in mice. We next evaluated the contribution of each mutation to the pattern of early viral dissemination. WT mice were inoculated in the left rear footpad with 10 3 PFU of AF15561, AF15561 E2 K200R;ΔUTR , AF15561 E2 K200R , or AF15561 ΔUTR . At 1 dpi, as expected, similar viral titers were detected in the left ankle regardless of the viral strain (Fig. 6C) . In contrast, both AF15561 E2 K200R;ΔUTR and AF15561 E2 K200R rapidly disseminated to distant tissues and achieved higher viral loads in the right ankle and quadriceps than those in mice infected with AF15561 (Fig. 6C) . Similarly, AF15561 E2 K200R;ΔUTR -and AF15561 E2 K200R -infected mice had a higher level of viremia than did AF15561-infected mice (Fig. 6C) . No differences in viral loads in tissues were detected in mice infected with AF15561 ΔUTR compared with AF15561-infected mice. Collectively, these data suggest that the E2 K200R mutation enhances the capacity of the virus to disseminate from the site of inoculation, whereas the deletion in the 3=-UTR is dispensable for these effects.
DISCUSSION
Several studies have established that mice deficient in adaptive immune responses develop persistent CHIKV infection in multiple tissues for weeks (23- 25, 28, 31, 40) . The amount of IFN-␣ in serum of mock-infected (n ϭ 3/group), AF15561-infected (n ϭ 8-9/group), or AF15561 E2 K200R;ΔUTR -infected (n ϭ 8 to 9/group) mice was quantified by an ELISA. (C) Ifnar1 Ϫ/Ϫ C57BL/6 mice were inoculated with 10 3 PFU of AF15561 or AF15561 E2 K200R;ΔUTR in the left rear footpad. At 1 dpi, the amount of infectious virus in the indicated tissues was quantified by a focus-forming assay. Dashed lines indicate the limit of detection. Data are derived from results from two independent experiments. P values were determined by Mann-Whitney tests (A and C) or one-way ANOVA with Tukey's multiple-comparison test (B). *, P Ͻ 0.05; **, P Ͻ 0.01; ***, P Ͻ 0.001.
Despite sustaining chronic viral replication for as long as 500 days, Rag1 Ϫ/Ϫ mice exhibit only mild to moderate signs of joint pathology along with modestly elevated serum levels of tumor necrosis factor (TNF), interleukin-6 (IL-6), and IFN-␥ (24, 25) . Thus, the isolation of an adapted, more pathogenic, strain of CHIKV from the serum of a Rag1 Ϫ/Ϫ mouse was unexpected. However, the isolation of a neurovirulent strain of Sindbis virus from the brains of persistently infected severe combined immune deficiency (scid) mice was previously reported (41) , suggesting that persistent replication in immunodeficient mice can select for more pathogenic alphaviruses. Our findings are in contrast to those of a previous study in which CHIKV isolated from the serum of Rag1 Ϫ/Ϫ mice at 100 dpi did not show enhanced fitness when inoculated into WT mice (25) . Similarly, CHIKV isolated from the kidney or brain of Rag1 Ϫ/Ϫ mice at 4 to 6 weeks postinfection showed a limited number of coding changes, all within the nonstructural proteins (40) , although the effects of these mutations on CHIKV replication and pathogenesis were not evaluated. It is possible that differences in the mouse models (young versus adult mice), founder strains of CHIKV (East, Central, and South African [ECSA] versus Asian genotype), and sources of infectious virus for the inoculum (serum in our study or cell culture passage in the previous study [25] ) may account for these differences. Indeed, in our own studies, one mouse receiving serum-derived AF15561 exhibited less severe musculoskeletal disease and weight loss, suggesting that AF15561 circulating in the serum of Rag1 Ϫ/Ϫ mice may be heterogeneous. This is supported by our sequencing results for six plaque-purified isolates from the serum of one chronically infected Rag1 Ϫ/Ϫ mouse, which displayed heterogeneity at E2 residue 200 and in the 3=-UTR. ) were determined daily. Data are derived from results from two independent experiments. P values were determined by two-way ANOVA with Bonferroni's multiple-comparison test. **, P Ͻ 0.01; ***, P Ͻ 0.001. The P values displayed are for AF15561 E2 K200R;ΔUTR versus AF15561 E2 K200R . (C) WT C57BL/6J mice were inoculated with 10 3 PFU of AF15561 (n ϭ 6), AF15561 E2 K200R;ΔUTR (n ϭ 6), AF15561 E2 K200R (n ϭ 6), or AF15561 ΔUTR (n ϭ 6) in the left rear footpad. At 1 dpi, mice were euthanized, and the amount of infectious virus in the indicated tissues was quantified by a focus-forming assay. Data are derived from results from two independent experiments. P values were determined by a Kruskal-Wallis test with Dunn's multiple-comparison test. *, P Ͻ 0.05; **, P Ͻ 0.01; ***, P Ͻ 0.001.
Although AF6811P2 was isolated from serum, which tissues or cell types in Rag1 Ϫ/Ϫ mice shed CHIKV into the circulation are unknown. In contrast to serum, inoculation of ankle tissue homogenates, which contained infectious CHIKV, from persistently infected Rag1 Ϫ/Ϫ mice did not result in more severe disease signs, suggesting that discrete populations of CHIKV with various fitnesses exist within the same host. Further studies of these populations may provide insight into tissue-specific selective pressures exerted on CHIKV during acute and chronic infections.
The host pressures that selected for the adaptive mutations are unknown. Rag1 Ϫ/Ϫ mice can limit CHIKV replication in the absence of adaptive immune responses (24, 25) , likely through type I IFN and other innate immune responses. Mice deficient in the type I IFN response rapidly succumb to CHIKV infection within days of infection (26, (35) (36) (37) (38) , demonstrating an essential requirement for this immune arm to control early CHIKV replication and dissemination. Passage of the related Semliki Forest virus (SFV) in mice resulted in a strain of SFV (L10) that was resistant to control by the type I IFN response (42) . Accordingly, an attractive hypothesis was that the increased pathogenicity and replicative capacity of the adapted CHIKV strain in mice was due to greater resistance to the host type I IFN response. However, our studies with Irf3 Ϫ/Ϫ Irf7 Ϫ/Ϫ DKO and Ifnar1 Ϫ/Ϫ mice suggest that the enhanced viral dissemination conferred by the E2 K200R mutation is independent of the antagonism of type I IFN antiviral responses mediated via IFNAR1. The role that increased resistance to type I IFN responses may play at later stages of the pathogenic sequence remains to be investigated, as Irf3 Ϫ/Ϫ Irf7 Ϫ/Ϫ DKO and Ifnar1 Ϫ/Ϫ mice infected with CHIKV rapidly succumb to infection.
Our analyses of tissue viral burden, tissue histopathology, and disease signs in mice indicate that the AF6811P2 and AF15561 E2 K200R;ΔUTR CHIKV strains retain tropism for musculoskeletal tissues and cause musculoskeletal disease. In addition, mice infected with AF15561 E2 K200; ΔUTR developed viremia with a higher magnitude and a longer duration than did mice infected with most WT CHIKV strains, a feature that is consistent with CHIKV-infected humans and nonhuman primates, which also develop a remarkably high level of viremia (20, (43) (44) (45) (46) (47) (48) . The higher viral loads in the quadriceps muscle of AF15561 E2 K200R;ΔUTR -infected mice likely contribute to more severe musculoskeletal disease, as disease severity correlates with increased viral burdens in muscle tissue in CHIKV-and Ross River virus-infected mice (34, 38, 49) .
Our data indicate that the E2 K200R mutation is sufficient to enhance CHIKV dissemination and pathogenicity in mice. However, the mechanisms by which this mutation influences viral dissemination and pathogenesis remain to be determined. E2 residue K200 is highly conserved among strains of all three CHIKV genotypes, with 333/335 CHIKV genomes in the ViPR database (33) encoding a K residue at this position. The remaining two strains encoded an R residue at this position. The CHIKV E2 glycoprotein forms a dimer with the E1 glycoprotein, and three dimers form one of the 80 spikes on the surface on the virion (32). E2 is highly exposed on the virion and is responsible for receptor binding while also being the primary target of neutralizing antibody responses (28, 30, 50) . Based on the X-ray crystal structure of the CHIKV E2-E1 heterodimer, E2 residue K200 makes van der Waals contacts with highly conserved E1 residues (C63 and F95) located near or in the conserved E1 fusion loop (32) , suggesting that the K200R mutation might alter E2-E1 interactions at this site (Fig. 1D) . E2-E1 interactions in related alphaviruses have been shown to regulate pH-mediated structural changes (51, 52) that are a requisite for the entry of the virus into the cytoplasm (53, 54) . Mutations in E2 can also influence virion assembly and release in a cell-and host-specific manner (55) (56) (57) , dictate viral tropism and pathogenesis in vivo (58) (59) (60) (61) (62) , and modulate vector competence (63, 64) . Further studies are needed to examine whether the E2 K200R mutation influences CHIKV cellular tropism, the pH of fusion, virus assembly and release, or other unknown mechanisms.
Our comparison of AF15561 containing the 3=-UTR deletion alone, AF15561 ΔUTR , and the double mutant strain AF15561 E2 K200R;ΔUTR suggests that the 44-nt deletion in the 3=-UTR also contributes to enhanced virulence in mice. The CHIKV 3=-UTR contains direct-repeat elements formed by duplications within the 3=-UTR (65). Asian genotype viruses (e.g., AF15561) encode a divergent 3=-UTR compared to those of strains of the West African and ECSA genotypes. This divergent 3=-UTR likely was formed by a large deletion in the 3=-UTR and the subsequent accumulation of adaptive mutations and duplications due to founder effects, as the Asian genotype diverged from an ECSA genotype virus (65) . The recent identification of a novel duplication in Asian-American CHIKV isolates suggests that the Asian genotype 3=-UTR is still under selective pressures (66) . The 44-nt deletion identified in the virus persistently circulating in Rag1 Ϫ/Ϫ mice occurs in a region of the 3=-UTR, element 3B, that is unique to Asian genotype viruses (Fig. 1E) . Thus, the effects of the 44-nt deletion on pathogenicity may be constrained to Asian genotype viruses. However, the 3A element, present in all genotypes of CHIKV, contains a similar sequence that differs by only 1 to 4 nt from the 44-nt deletion in 3B. Further studies are needed to determine if the 3B deletion uniquely affects CHIKV pathogenicity in mice or whether manipulation of the 3A element, present in all CHIKV genotypes, can result in similar effects. The function of the 3=-UTR in alphaviral replication and pathogenesis is largely unknown, as alphaviruses exhibit significant heterogeneity in this region (67) (68) (69) . Modulation of the 3=-UTR often results in a fitness cost in mosquito cells or whole mosquitoes, whereas large deletions are tolerated in mammalian cells (70) (71) (72) . However, the 3=-UTR is important for the stability of the viral genome and likely interacts with host factors to facilitate viral replication (73, 74) . CHIKV and other alphavirus 3=-UTRs interact with the host HuR protein, which protects the viral RNA from degradation and increases virus yields (75) (76) (77) . The viral 3=-UTR also can impact viral tropism and host innate immune responses to RNA virus infection. A microRNA (miRNA) binding site in the 3=-UTR of eastern equine encephalitis virus for a myeloid cell-specific miRNA restricts viral replication in myeloid cells, which delays the induction of the type I IFN response (72) . West Nile virus, an unrelated flavivirus, also encodes a miRNA in its 3=-UTR that enhances replication in mosquito cells (78) , and an RNA secondary structure in flavivirus 3=-UTRs can influence viral replication and innate responses to infection (79) . Given these diverse functions of the 3=-UTR, it remains to be determined if the deletion in the 3=-UTR alleviates restriction by a host factor, alters interactions with host proteins that facilitate viral replication, or modulates other pathways to enhance viral pathogenicity in mice.
Our isolation of a CHIKV strain with enhanced virulence in mice and the identification of the E2 K200R mutation and the 3=-UTR deletion defined new determinants of CHIKV virulence. Understanding the mechanisms by which these mutations in E2 and the 3=-UTR contribute to enhanced dissemination and acute and chronic pathogenesis in mice of different ages may provide insight for controlling CHIKV infection and preventing persistence. Finally, infection of mice by this strain recapitulates the high level viremia and more severe disseminated acute musculoskeletal disease reported for humans, which could lead to improvements in the mouse model of CHIKV infection and disease. These advancements may have utility for defining mechanisms of acute and chronic disease pathogenesis and for evaluating vaccine candidates and host-and virus-targeted therapeutics.
MATERIALS AND METHODS
Ethics statement. This study was conducted in accordance with recommendations in the Guide for the Care and Use of Laboratory Animals (80) and AVMA guidelines for the euthanasia of animals (88) . All animal experiments conducted at the University of Colorado Anschutz Medical Campus were performed with the approval of the Institutional Animal Care and Use Committee (IACUC) at the University School of Medicine (assurance no. A3269-01) under protocol B-86514(10)1E. For studies with Ifnar1 Ϫ/Ϫ mice, the protocols were approved by the IACUC at the Washington University School of Medicine (assurance no. A3381-01).
Viruses. CHIKV strain AF15561 (GenBank accession no. EF452493) was isolated from a human patient during an outbreak of CHIKV in Thailand in 1962 and passaged twice in Vero cells (81, 82) . A cDNA clone of AF15561 was generated from 181/25 cDNA by using site-directed mutagenesis as previously described (58) . Virus stocks were generated by the electroporation of BHK-21 cells with in vitro-transcribed RNA as previously described (24) . Cell culture supernatants from electroporated cells were collected, clarified by centrifugation, and aliquoted. Stock virus titers were quantified by a plaque assay on BHK-21 or Vero cells.
containing the 44-nt deletion into AF15561 or AF15561 E2 K200R plasmids, the viral cDNA-carrying plasmids and the TOPO vector containing the AF6811P2 3=-UTR were subjected to sequential digestions with SgrDI (Thermo Fisher) and SspI (New England BioLabs). Fragments were ligated by using T4 DNA ligase (New England BioLabs). Due to a second SspI site in the pSinRep5 plasmid 200 bp downstream of the CHIKV poly(A) tail, this strategy resulted in the loss of the poly(A) tail and 200 bp of the plasmid backbone. To restore the poly(A) tail and plasmid backbone sequence, an unmutagenized AF15561 plasmid was digested with SspI to produce an ϳ200-bp fragment containing the authentic 3=-UTR and plasmid backbone. The cDNA plasmids lacking the poly(A) tail and 200 bp of the plasmid backbone were then linearized with SspI. The 200-bp fragment was then ligated into the linearized plasmids. Restoration of the poly(A) tail and plasmid backbone was confirmed by sequencing.
In vitro virus replication. Triplicate wells were inoculated with CHIKV at the indicated MOIs. Viruses were adsorbed onto cells for 1 h at 37°C. Wells were then washed three times with 1 ml of roomtemperature 1ϫ PBS. Growth medium was then added to each well, and cells were incubated at 37°C. For cumulative growth analysis, 100-l samples of culture supernatants were removed at various times p.i., and an equal volume of fresh growth medium was added to maintain a constant volume within each well. Samples were stored at Ϫ80°C for analysis by a focus-forming assay.
Plaque and focus-forming assays. To quantify the amount of infectious virus in samples, either a plaque assay or a focus-forming assay was used. For plaque assays, BHK-21 cells were seeded into 6-well dishes. Samples containing the virus were serially diluted in a solution containing PBS, 1% FBS, 1ϫ Ca 2ϩ , and 1ϫ Mg 2ϩ and adsorbed onto the cells for 1 h at 37°C. Cells were overlaid with 1% immunodiffusion agarose (MP Biomedicals), and plaques were allowed to form for 36 to 40 h at 37°C. Plaques were visualized with a neutral red stain, and titers were enumerated as plaques per milliliter of serum or gram of tissue. For focus-forming assays, Vero cells were seeded into 96-well plates. Samples containing virus were serially diluted in DMEM-F-12 medium plus 2% FBS and allowed to adsorb onto the cells for 2 h at 37°C. At the end of 2 h, the sample was removed, and cells were overlaid with 0.5% methylcellulose in MEM-␣ plus 10% FBS and incubated at 37°C for 16 to 18 h. Cells were then fixed with 1% paraformaldehyde and probed with CHIKV-specific monoclonal antibody CHK-11 (87) at 500 ng/ml in Perm Wash (1ϫ PBS, 0.1% saponin, 0.1% bovine serum albumin [BSA] ). The antibody was allowed to bind for 2 h at room temperature. Next, cells were washed with Perm Wash, secondary goat anti-mouse IgG conjugated to horseradish peroxidase at a 1:2,000 dilution in Perm Wash was applied, and the mixture was incubated for 2 h at room temperature. Cells were washed with Perm Wash, and antigen-positive cells were visualized with the TrueBlue substrate (Fisher). Foci were counted with a CTL Biospot analyzer and Biospot software (Cellular Technology). Titers were calculated as the number of foci per milliliter of serum or gram of tissue.
Type I IFN ELISA. The IFN-␣ level in sera was measured by using a mouse IFN-␣ enzyme-linked immunosorbent assay (ELISA) (Pestka Biomedical Laboratories) (49) .
Histopathological analysis. At 7 dpi, mice were sacrificed and perfused by intracardiac injection of 4% paraformaldehyde (pH 7.3), and the indicated tissues were dissected and fixed in 4% paraformaldehyde (pH 7.3). Tissues were embedded in paraffin, and 5-m sections were prepared. Tissue sections were stained with hematoxylin and eosin (H&E) and evaluated by light microscopy. A board-certified veterinary anatomic pathologist scored the presence, distribution, and severity of histological lesions in muscle, joint space, synovium, tendon, and periarticular tissue in a blind manner. The following scoring system was used: 0 for no inflammation, 1 for Ͼ5 areas of small clusters of leukocytes, 2 for leukocytes forming larger clusters to thin tracts through tissue with multiple affected sites, 3 for clusters and tracts of leukocytes coalescing into at least one large area that displaces/replaces tissue, with or without necrosis and with or without mineralization, and 4 for leukocytes that are in aggregates large enough to replace Ͼ40% of normal tissue, with or without necrosis and with or without mineralization.
Statistical analysis. All data were analyzed by using GraphPad Prism 6 software. Data were evaluated for statistically significant differences by using a two-tailed, unpaired t test; Mann-Whitney tests; one-way analysis of variance (ANOVA) followed by Tukey's multiple-comparison test; two-way ANOVA followed by a Bonferroni multiple-comparison test, or a Kruskal-Wallis test with Dunn's multiplecomparison test. A P value of Ͻ0.05 was considered statistically significant.
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